Published in Mol Psychiatry on July 17, 2012
Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) (2013) 1.01
EU-AIMS: a boost to autism research. Nat Rev Drug Discov (2012) 0.95
Long non-coding RNAs in neurodevelopmental disorders. Front Mol Neurosci (2013) 0.95
Biomarkers in autism. Front Psychiatry (2014) 0.92
Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology (2014) 0.88
Atypical excitation-inhibition balance in autism captured by the gamma response to contextual modulation. Neuroimage Clin (2013) 0.86
Current progress and challenges in the search for autism biomarkers. Dis Markers (2013) 0.85
Hypersensitive pupillary light reflex in infants at risk for autism. Mol Autism (2015) 0.84
Neuroanatomy of Individual Differences in Language in Adult Males with Autism. Cereb Cortex (2014) 0.83
Characteristics of Brains in Autism Spectrum Disorder: Structure, Function and Connectivity across the Lifespan. Exp Neurobiol (2015) 0.82
Left-hemispheric microstructural abnormalities in children with high-functioning autism spectrum disorder. Autism Res (2014) 0.80
The innovative medicines initiative: a public private partnership model to foster drug discovery. Comput Struct Biotechnol J (2013) 0.80
Neural connectivity abnormalities in autism: insights from the Tuberous Sclerosis model. BMC Med (2013) 0.80
Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology (Berl) (2013) 0.80
Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates. Cortex (2015) 0.79
Brain imaging: closing the gap between basic research and clinical application is urgently needed. Eur Child Adolesc Psychiatry (2013) 0.77
PX-RICS-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABAA receptor trafficking. Nat Commun (2016) 0.76
New treatment perspectives in autism spectrum disorders. Front Pediatr (2015) 0.75
Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approach. Neuropsychiatry (London) (2013) 0.75
Systems biology as a comparative approach to understand complex gene expression in neurological diseases. Behav Sci (Basel) (2013) 0.75
Neuroanatomical Alterations in High-Functioning Adults with Autism Spectrum Disorder. Front Neurosci (2016) 0.75
Trialing targeted therapies for autism. Nat Med (2012) 0.75
Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder. Transl Psychiatry (2017) 0.75
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav (2003) 8.48
Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell (2000) 7.48
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Functional magnetic resonance imaging (fMRI) "brain reading": detecting and classifying distributed patterns of fMRI activity in human visual cortex. Neuroimage (2003) 7.22
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology (2001) 5.92
Neuroligins determine synapse maturation and function. Neuron (2006) 5.70
Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex (2006) 5.68
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature (2011) 5.62
Neuroanatomy of autism. Trends Neurosci (2008) 5.59
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med (2006) 5.28
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 5.11
Autism and abnormal development of brain connectivity. J Neurosci (2004) 4.93
The genetics of autism. Pediatrics (2004) 4.93
A genome-wide linkage and association scan reveals novel loci for autism. Nature (2009) 4.76
Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron (2011) 4.66
Two genes encode distinct glutamate decarboxylases. Neuron (1991) 3.68
Describing the brain in autism in five dimensions--magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J Neurosci (2010) 3.58
Diffusion tensor imaging of the corpus callosum in Autism. Neuroimage (2006) 3.48
Cell adhesion molecules: signalling functions at the synapse. Nat Rev Neurosci (2007) 3.47
Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage (2002) 3.28
Head circumference and height in autism: a study by the Collaborative Program of Excellence in Autism. Am J Med Genet A (2006) 3.01
Genetics of autism spectrum disorders. Trends Cogn Sci (2011) 2.61
Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord (2009) 2.61
Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc Natl Acad Sci U S A (2007) 2.56
fMRI investigation of working memory for faces in autism: visual coding and underconnectivity with frontal areas. Cereb Cortex (2007) 2.46
Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach. Neuroimage (2009) 2.28
Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain (2002) 2.26
Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain (2003) 2.24
Brain connectivity and high functioning autism: a promising path of research that needs refined models, methodological convergence, and stronger behavioral links. Neurosci Biobehav Rev (2011) 2.23
Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med (1988) 2.12
Trophic actions of GABA on neuronal development. Trends Neurosci (2005) 2.06
Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch Gen Psychiatry (2011) 2.04
Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med (2009) 1.99
Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain (2004) 1.97
Superior temporal sulcus anatomical abnormalities in childhood autism: a voxel-based morphometry MRI study. Neuroimage (2004) 1.93
Disordered connectivity in the autistic brain: challenges for the "new psychophysiology". Int J Psychophysiol (2006) 1.91
Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol (1999) 1.90
An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry (1999) 1.82
SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry (2011) 1.79
Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med (2010) 1.72
Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry (2007) 1.70
Deviant functional magnetic resonance imaging patterns of brain activity to speech in 2-3-year-old children with autism spectrum disorder. Biol Psychiatry (2008) 1.65
Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res Dev Disabil (2011) 1.65
Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Dev Neurosci (2005) 1.65
Atypical diffusion tensor hemispheric asymmetry in autism. Autism Res (2010) 1.64
Functional disconnectivity of the medial temporal lobe in Asperger's syndrome. Biol Psychiatry (2005) 1.64
Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62
The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans. Neuroreport (1999) 1.59
Regional gray matter volumetric changes in autism associated with social and repetitive behavior symptoms. BMC Psychiatry (2006) 1.59
Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast (2011) 1.56
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry (2010) 1.53
Altered cerebellar feedback projections in Asperger syndrome. Neuroimage (2008) 1.42
Brain anatomy and its relationship to behavior in adults with autism spectrum disorder: a multicenter magnetic resonance imaging study. Arch Gen Psychiatry (2012) 1.40
A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol Psychiatry (2006) 1.39
Diffusion based abnormality markers of pathology: toward learned diagnostic prediction of ASD. Neuroimage (2011) 1.37
Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism. Mol Psychiatry (2009) 1.36
Clinical and macroscopic correlates of minicolumnar pathology in autism. J Child Neurol (2002) 1.30
In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry (2006) 1.29
Predictive models of autism spectrum disorder based on brain regional cortical thickness. Neuroimage (2009) 1.28
White matter fractional anisotrophy differences and correlates of diagnostic symptoms in autism. J Child Psychol Psychiatry (2009) 1.26
Mapping gray matter development: implications for typical development and vulnerability to psychopathology. Brain Cogn (2009) 1.24
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2010) 1.23
The anatomy of extended limbic pathways in Asperger syndrome: a preliminary diffusion tensor imaging tractography study. Neuroimage (2009) 1.23
Multi-voxel pattern analysis of fMRI data predicts clinical symptom severity. Neuroimage (2011) 1.21
Multivariate searchlight classification of structural magnetic resonance imaging in children and adolescents with autism. Biol Psychiatry (2011) 1.20
New potential leads in the biology and treatment of attention deficit-hyperactivity disorder. Curr Opin Neurol (2007) 1.16
Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry (2007) 1.11
Serotonin and the neural processing of facial emotions in adults with autism: an fMRI study using acute tryptophan depletion. Arch Gen Psychiatry (2012) 1.10
Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Brain (2001) 1.09
Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry (2002) 1.09
Female children with autism spectrum disorder: an insight from mass-univariate and pattern classification analyses. Neuroimage (2011) 1.07
Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry (2006) 1.06
White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults. Autism Res (2010) 1.02
The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study. Neuropharmacology (2012) 1.02
SHANK3, the synapse, and autism. N Engl J Med (2011) 1.01
Abnormal early brain development in autism. Mol Psychiatry (2002) 1.00
The minicolumn and evolution of the brain. Brain Behav Evol (2002) 0.97
Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord (2006) 0.97
Examination of association of genes in the serotonin system to autism. Neurogenetics (2009) 0.93
Neuronal density and architecture (Gray Level Index) in the brains of autistic patients. J Child Neurol (2002) 0.93
Association of tryptophan 2,3 dioxygenase gene polymorphism with autism. Am J Med Genet B Neuropsychiatr Genet (2004) 0.93
Feature selection and classification of imbalanced datasets: application to PET images of children with autistic spectrum disorders. Neuroimage (2011) 0.84
The neurochemical basis for the treatment of autism spectrum disorders and Fragile X Syndrome. Biochem Pharmacol (2011) 0.83
Predictive models for subtypes of autism spectrum disorder based on single-nucleotide polymorphisms and magnetic resonance imaging. Adv Med Sci (2011) 0.77
Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci (2000) 3.14
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron (2001) 2.51
Altered connections on the road to psychopathy. Mol Psychiatry (2009) 1.38
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology (2001) 1.16
Frontotemporal white-matter microstructural abnormalities in adolescents with conduct disorder: a diffusion tensor imaging study. Psychol Med (2012) 1.06
An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS). Neuropsychologia (2002) 1.04
Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine. Psychopharmacology (Berl) (2010) 1.02
Estrogen therapy and Alzheimer's dementia. Ann N Y Acad Sci (2010) 1.01
Clinical and anatomical heterogeneity in autistic spectrum disorder: a structural MRI study. Psychol Med (2009) 1.01
Genetic variation in the serotonin transporter modulates neural system-wide response to fearful faces. Genes Brain Behav (2008) 0.99
Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br J Pharmacol (2008) 0.95
Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome. Psychol Med (2007) 0.95
Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults. Psychol Med (2008) 0.95
Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats. Neuropharmacology (2007) 0.92
The effect of age, diagnosis, and their interaction on vertex-based measures of cortical thickness and surface area in autism spectrum disorder. J Neural Transm (Vienna) (2014) 0.91
Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI study. Psychol Med (2009) 0.91
Cognitive performance in neurokinin 3 receptor knockout mice. Psychopharmacology (Berl) (2008) 0.90
Alzheimer's disease and Down's syndrome: an in vivo MRI study. Psychol Med (2008) 0.88
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders. Growth Horm IGF Res (2011) 0.87
Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment. Psychopharmacology (Berl) (2004) 0.86
Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. Psychopharmacology (Berl) (2008) 0.85
Allosteric modulators for mGlu receptors. Curr Neuropharmacol (2007) 0.83
Oestrogen, brain function, and neuropsychiatric disorders. J Neurol Neurosurg Psychiatry (2003) 0.83
Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study. Horm Behav (2007) 0.80
Adults with attention deficit hyperactivity disorder: an investigation of age-related differences in behavioural symptoms, neuropsychological function and co-morbidity. Psychol Med (2012) 0.80
Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women--a preliminary study. Psychoneuroendocrinology (2004) 0.80
Developing new pharmacotherapies for autism. J Intern Med (2013) 0.79
Psychological treatment for obsessive-compulsive disorder in people with autism spectrum disorders--a pilot study. Psychother Psychosom (2008) 0.78
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors. Br J Pharmacol (2011) 0.77
Mouse models of alpha-synucleinopathy and Lewy pathology. Exp Gerontol (2000) 0.77
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article. Amino Acids (2002) 0.77
Anatomically distinct output channels of the caudate nucleus and orofacial dyskinesia: critical role of the subcommissural part of the globus pallidus in oral dyskinesia. Neuroscience (1989) 0.75
Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women. Psychoneuroendocrinology (2003) 0.75
Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice. Adv Exp Med Biol (2001) 0.75
In vivo imaging of muscarinic receptors in the aging female brain with (R,R)[123I]-I-QNB and single photon emission tomography. Exp Gerontol (2004) 0.75